Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Retained Earnings (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Retained Earnings for 13 consecutive years, with -$692000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Retained Earnings rose 99.72% to -$692000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$692000.0, a 99.72% increase, with the full-year FY2025 number at -$692000.0, up 99.72% from a year prior.
  • Retained Earnings was -$692000.0 for Q4 2025 at Ekso Bionics Holdings, up from -$700000.0 in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $733000.0 in Q3 2023 to a low of -$256.3 million in Q2 2025.
  • A 5-year average of -$116.9 million and a median of -$107.1 million in 2022 define the central range for Retained Earnings.
  • Peak YoY movement for Retained Earnings: plummeted 1317235.29% in 2022, then surged 100.33% in 2023.
  • Ekso Bionics Holdings' Retained Earnings stood at -$17000.0 in 2021, then tumbled by 1317235.29% to -$223.9 million in 2022, then fell by 6.79% to -$239.1 million in 2023, then fell by 4.74% to -$250.5 million in 2024, then surged by 99.72% to -$692000.0 in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Retained Earnings are -$692000.0 (Q4 2025), -$700000.0 (Q3 2025), and -$256.3 million (Q2 2025).